Calendar Neurocrine Biosciences, Inc.

Equities

NBIX

US64125C1099

Pharmaceuticals

Market Closed - Nasdaq Other stock markets 02:30:00 06/12/2025 am IST			5-day change	1st Jan Change
155.51 ^USD	+0.84%		+2.20%	+13.93%

05/12	Neurocrine Biosciences Insider Sold Shares Worth $2,289,083, According to a Recent SEC Filing	MT
03/12	Neurocrine Biosciences Insider Sold Shares Worth $905,881, According to a Recent SEC Filing	MT

Chart calendar Neurocrine Biosciences, Inc.

9d64c39933a.KsElOQXidi1y2kIRZYrmelayz6SvzFY4EL9b7RnQd4A.efBWfVykR0sVjzpGU8TQPgbwgsydrRMJSOgXg2mzIMxAplRIVY0XZESqKQ~d4051470194da2eda394325781179ec4

Upcoming events on Neurocrine Biosciences, Inc.

11/02/2026	Q4 2025 Earnings Release (Projected)	Add to your calendar Google Apple ICS format
06/05/2026	Q1 2026 Earnings Release (Projected)	Add to your calendar Google Apple ICS format
04/08/2026	Q2 2026 Earnings Release (Projected)	Add to your calendar Google Apple ICS format
03/11/2026	Q3 2026 Earnings Release (Projected)	Add to your calendar Google Apple ICS format

Past events on Neurocrine Biosciences, Inc.

02/12/2025	Piper Sandler Healthcare Conference
18/11/2025	Jefferies Global Healthcare Conference
29/10/2025	Q3 2025 Earnings Call
29/10/2025	Q3 2025 Earnings Release
19/09/2025	Psych Congress
17/09/2025	TD Cowen Novel Mechanisms in Neuropsychiatry & Epilepsy Summit
10/09/2025	Baird Healthcare Conference
09/09/2025	Morgan Stanley Global Healthcare Conference
03/09/2025	Cantor Global Healthcare Conference
13/08/2025	Canaccord Genuity Growth Conference
31/07/2025	Q2 2025 Earnings Call
31/07/2025	Q2 2025 Earnings Release
21/05/2025	Annual General Meeting
20/05/2025	RBC Global Healthcare Conference
13/05/2025	Bank of America Global Healthcare Conference
06/05/2025	Q1 2025 Earnings Call
06/05/2025	Q1 2025 Earnings Release
31/03/2025	Academy of Managed Care Pharmacy Meeting
18/03/2025	Stifel Virtual CNS Forum
11/03/2025	Leerink Partners Global Healthcare Conference

Annual results

Fiscal Period	December	2022	2023	2024	2025	2026	2027
Net sales Million USD	Released Forecast Spread	1 489 1 484 0.31%	1 887 1 885 0.1%	2 355 2 356 -0.04%	2 856	3 378	3 695
EBITDA Million USD	Released Forecast Spread	264 336 -21.3%	269 281 -4.33%	598 626 -4.6%	663	780	1 019
EBIT Million USD	Released Forecast Spread	249 289 -13.9%	251 258 -2.84%	571 617 -7.49%	638	883	1 098
Earnings before Tax (EBT) Million USD	Released Forecast Spread	214 241 -11.43%	332 296 12.11%	486 560 -13.19%	702	919	1 125
Net income Million USD	Released Forecast Spread	155 188 -17.63%	250 225 11.11%	341 423 -19.31%	512	702	853
EPS USD	Released Forecast Spread	1,56 1,88 -17.15%	2,47 2,22 11.3%	3,29 4,02 -18.19%	5,04	6,95	8,33
Announcement Date		06/02/23	07/02/24	06/02/25	-

Quarterly results

Fiscal Period	September	2024 Q1	2024 Q2	2024 Q3	2024 Q4	2025 Q1	2025 Q2	2025 Q3	2025 Q4	2026 Q1	2026 Q2	2026 Q3	2026 Q4
Net sales Million USD	Released Forecast Spread	515 512 0.64%	590 547 7.98%	622 603 3.21%	628 629 -0.28%	573 561 2.07%	688 654 5.14%	795 747 6.38%	805	774	838	883	910
EBITDA Million USD	Released Forecast Spread	106 127 -16.67%	153 146 4.66%	190 190 0.37%	149 191 -21.77%	31,2 64,8 -51.82%	152 135 12.65%	188	241	153	156	131	145
EBIT Million USD	Released Forecast Spread	99,3 118 -15.82%	145 145 0.49%	184 182 0.82%	142 189 -25.03%	23,6 49,6 -52.43%	146 128 13.4%	239 197 21.3%	234	168	201	231	275
Earnings before Tax (EBT) Million USD	Released Forecast Spread	34,5 129 -73.3%	98,6 138 -28.5%	190 195 -2.28%	163 206 -21.14%	14,7 73,0 -79.85%	160 135 18.1%	292 205 42.47%	242	174	213	243	288
Net income Million USD	Released Forecast Spread	43,4 101 -57.11%	65,0 114 -42.98%	130 151 -13.99%	103 159 -35.06%	7,90 48,6 -83.74%	108 98,5 9.15%	210 159 31.64%	189	132	166	190	222
EPS USD	Released Forecast Spread	0,42 1,00 -57.99%	0,63 1,03 -39.12%	1,24 1,45 -14.31%	1,00 1,51 -33.87%	0,08 0,50 -83.95%	1,06 0,99 7.54%	2,04 1,59 28.39%	1,89	1,50	1,77	1,91	2,09
Announcement Date		01/05/24	01/08/24	30/10/24	06/02/25	05/05/25	30/07/25	28/10/25	-	-	-	-	-

Upcoming sector events for Neurocrine Biosciences, Inc.

09/12/2025	MEDINCELL S.A.	Q2 2026 Earnings Release	Add to your calendar Google Apple ICS format
06/01/2026	HISAMITSU PHARMACEUTICAL CO., INC.	Q3 2025 Earnings Release	Add to your calendar Google Apple ICS format
12/01/2026	TILRAY BRANDS, INC.	Q2 2026 Earnings Release (Projected)	Add to your calendar Google Apple ICS format
16/01/2026	SUPRIYA LIFESCIENCE LIMITED	Q3 2026 Earnings Release (Projected)	Add to your calendar Google Apple ICS format
21/01/2026	JOHNSON & JOHNSON	Q4 2025 Earnings Release	Add to your calendar Google Apple ICS format
21/01/2026	HANALL BIOPHARMA CO., LTD.	Q4 2025 Earnings Release (Projected)	Add to your calendar Google Apple ICS format
22/01/2026	LAURUS LABS LIMITED	Q3 2026 Earnings Release (Projected)	Add to your calendar Google Apple ICS format
22/01/2026	ALIVUS LIFE SCIENCES LIMITED	Q3 2026 Earnings Release (Projected)	Add to your calendar Google Apple ICS format
22/01/2026	TORRENT PHARMACEUTICALS LIMITED	Q3 2026 Earnings Release (Projected)	Add to your calendar Google Apple ICS format
23/01/2026	DR. REDDY'S LABORATORIES LIMITED	Q3 2026 Earnings Release (Projected)	Add to your calendar Google Apple ICS format

More events

Past sector events for Neurocrine Biosciences, Inc.

05/12/2025	TTY BIOPHARM COMPANY LIMITED	November 2025 Sales and Revenue Release
01/12/2025	INVENTAGE LAB, INC.	Q3 2025 Earnings Release
28/11/2025	DOTTIKON ES HOLDING AG	Q2 2026 Earnings Release
20/11/2025	CSPC PHARMACEUTICAL GROUP LIMITED	Q3 2025 Earnings Release
14/11/2025	SEQUENT SCIENTIFIC LIMITED	Q2 2026 Earnings Release
14/11/2025	NATCO PHARMA LIMITED	Q2 2026 Earnings Release
14/11/2025	BAVARIAN NORDIC A/S	Q3 2025 Earnings Release
14/11/2025	DONGKOOK PHARMACEUTICAL CO., LTD.	Q3 2025 Earnings Release
14/11/2025	GREEN CROSS HOLDINGS CORPORATION	Q3 2025 Earnings Release
14/11/2025	KATAKURA INDUSTRIES CO.,LTD.	Q3 2025 Earnings Release